Sign in

Back to Explore

BioReview

Thoughts, stories and ideas.

On the social web

Subscribe via Mastodon, Threads, Flipboard, or any social web platform.

Latest Posts

Beyond GLP-1: Roche's $2.3B Bet on Muscle-Sparing Obesity Science

BioReview · 25 Aug 2026

Alzheimer's Treatment Comes Home: What the FDA's Lecanemab Subcutaneous Approval Really Changes

BioReview · 24 Aug 2026

One Gene, One Dose: What Ultragenyx's Genglycos Approval Means for Rare Metabolic Disease and the Gene Therapy Era

BioReview · 21 Aug 2026

Contributors

BioReview

BioReview

Creator of BioReview

More from Science

Mac Observatory

Thoughts, stories and ideas.

Mineral Minutes icon

Mineral Minutes

MSDC Monthly Newsletter

Parallel Bio icon

Parallel Bio

The official knowledge center of Parallel Bio.

folly

nonsensically good insights into research and current events